We have brought together world-class investors who share our aspirations to build the next great biotechnology company.
Our investors share our commitment to deliver on the promise of our technology, and our vision to create therapies for over a thousand genetic diseases affecting patients in need.
Our RAP Platform™ has limitless therapeutic potential. Given the enormity of the opportunity, we can’t do it all alone.
We believe our technology and unparalleled understanding of regRNAs combined with the specificity and potency of ASOs can usher in a new era of genetic medicines.